Background The ELCID Trial was a feasibility randomised controlled trial examining the effect on lung cancer diagnosis of lowering the threshold for referral for urgent chest X-ray for smokers and recent ex-smokers, aged over 60 with new chest symptoms. The qualitative component aimed to explore the feasibility of individually randomising patients to an urgent chest X-ray or not and to investigate any barriers to patient recruitment and participation. This would inform the design of any future definitive trial. This paper explores general practice staff insights into participating in and recruiting to diagnostic trials for possible/suspected lung cancer. Methods Qualitative interviews were conducted with 11 general practice staff which in...
Background: Recruitment of patients is one of the main challenges when designing and conducting rand...
Identifying subjects for clinical trials is difficult and the evidence base for recruitment strategi...
The ECLS trial is funded by the Chief Scientist Office of the Scottish Government and Oncimmune Ltd....
Background The ELCID Trial was a feasibility randomised controlled trial examining the effect on lu...
Background: The ELCID (Early Lung Cancer Investigation and Diagnosis) trial was a feasibility random...
BACKGROUND: The ELCID (Early Lung Cancer Investigation and Diagnosis) trial was a feasibility random...
BACKGROUND: The ELCID (Early Lung Cancer Investigation and Diagnosis) trial was a feasibility random...
Background The ELCID Trial is a feasibility randomised controlled trial examining the effect on lu...
Background: Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in th...
BackgroundA common challenge for randomised controlled trials (RCTs) is recruiting enough participan...
Background: The ELCID (Early Lung Cancer Investigation and Diagnosis) trial was a feasibility random...
Background: Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in th...
Context: The importance of evidence from randomised trials is now widely recognised, although recrui...
Published onlineJournal ArticleThis is the author accepted manuscript. The final version is availabl...
This study is supported by a PhD studentship provided by the University of St Andrews.Background: Ra...
Background: Recruitment of patients is one of the main challenges when designing and conducting rand...
Identifying subjects for clinical trials is difficult and the evidence base for recruitment strategi...
The ECLS trial is funded by the Chief Scientist Office of the Scottish Government and Oncimmune Ltd....
Background The ELCID Trial was a feasibility randomised controlled trial examining the effect on lu...
Background: The ELCID (Early Lung Cancer Investigation and Diagnosis) trial was a feasibility random...
BACKGROUND: The ELCID (Early Lung Cancer Investigation and Diagnosis) trial was a feasibility random...
BACKGROUND: The ELCID (Early Lung Cancer Investigation and Diagnosis) trial was a feasibility random...
Background The ELCID Trial is a feasibility randomised controlled trial examining the effect on lu...
Background: Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in th...
BackgroundA common challenge for randomised controlled trials (RCTs) is recruiting enough participan...
Background: The ELCID (Early Lung Cancer Investigation and Diagnosis) trial was a feasibility random...
Background: Achieving earlier stage diagnosis is one option for improving lung cancer outcomes in th...
Context: The importance of evidence from randomised trials is now widely recognised, although recrui...
Published onlineJournal ArticleThis is the author accepted manuscript. The final version is availabl...
This study is supported by a PhD studentship provided by the University of St Andrews.Background: Ra...
Background: Recruitment of patients is one of the main challenges when designing and conducting rand...
Identifying subjects for clinical trials is difficult and the evidence base for recruitment strategi...
The ECLS trial is funded by the Chief Scientist Office of the Scottish Government and Oncimmune Ltd....